Causes of T lymphocyte activation in HIV-infected patients coinfected with hepatitis C virus

Causes of T lymphocyte activation in HIV-infected patients coinfected with hepatitis C virus

Aim. To establish the causes of T lymphocyte activation in human immunodeficiency virus (HIV)-infected patients coinfected with hepatitis C (HCV) who are adherent to their antiretroviral therapy regimen and interferon untreated. Subjects and methods. Examinations were made in 62 people who were HIV+...

Full description

Bibliographic Details
Main Authors:	K V Shmagel, N G Shmagel, L B Korolevskaya, E V Saydakova, V A Chereshnev
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2016-11-01
Series:	Терапевтический архив
Subjects:	hiv/hcv coinfection antiretroviral therapy activation of immunity proliferation destruction of the intestinal barrier
Online Access:	https://ter-arkhiv.ru/0040-3660/article/viewFile/32054/pdf

Similar Items

ROLE OF HEPATITIS C VIRUS COINFECTION IN VIOLATION OF PRODUCTIVE THYMIC FUNCTION IN HIV-INFECTED PATIENTS UNDER IMMUNOLOGICALLY INEFFICIENT ANTIRETROVIRAL THERAPY
by: E. V. Saidakova, et al.
Published: (2014-07-01)

In HIV-infected patients, intestinal bacteria-derived products interfere with CD4<sup>+</sup>T cell regeneration
by: L. B. Korolevskaya, et al.
Published: (2023-06-01)

Immunological and Clinical Impact of DAA-Mediated HCV Eradication in a Cohort of HIV/HCV Coinfected Patients: Monocentric Italian Experience
by: Andrea Marino, et al.
Published: (2021-12-01)

Impact of HCV Eradication on Lipid Metabolism in HIV/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort Study
by: Martina Spaziante, et al.
Published: (2021-07-01)

HIV/HCV coinfection model: a fractional-order perspective for the effect of the HIV viral load
by: Ana RM Carvalho, et al.
Published: (2018-01-01)

Insights Into the Coinfections of Human Immunodeficiency Virus-Hepatitis B Virus, Human Immunodeficiency Virus-Hepatitis C Virus, and Hepatitis B Virus-Hepatitis C Virus: Prevalence, Risk Factors, Pathogenesis, Diagnosis, and Treatment
by: Sagarika Shahriar, et al.
Published: (2022-02-01)

Modeling the effect of HIV coinfection on clearance and sustained virologic response during treatment for hepatitis C virus
by: Ruthie Birger, et al.
Published: (2015-09-01)

Corrigendum: Insights into the coinfections of human immunodeficiency virus-hepatitis B virus, human immunodeficiency virus-hepatitis C virus, and hepatitis B virus-hepatitis C virus: prevalence, risk factors, pathogenesis, diagnosis, and treatment
by: Sagarika Shahriar, et al.
Published: (2023-08-01)

Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: a multicenter regional simulation
by: Cenderello G, et al.
Published: (2015-12-01)

Decreased in Liver Fibrosis in Patients with HCV/HIV Coinfection After Treatment with Sofosbuvir/Daclatasvir
by: Andreas Jonathan, et al.
Published: (2020-07-01)

HCV eradication in people living with HIV: the final countdown?
by: A. De Vito, et al.
Published: (2021-02-01)

Hepatitis C Virus Influences HIV-1 Viral Splicing in Coinfected Patients
by: Paula Martínez-Román, et al.
Published: (2020-07-01)

Regulatory T cell subsets in peripheral blood of HIV-infected patients with discordant response to antiretroviral therapy
by: L. B. Korolevskaya, et al.
Published: (2020-04-01)

Liver Stiffness Hinders Normalization of Systemic Inflammation and Endothelial Activation after Hepatitis C Virus (HCV) Eradication in HIV/HCV Coinfected Patients
by: Beatriz Álvarez, et al.
Published: (2020-06-01)

HCV-HIV Chronic Coinfection Prevalence in Amazon Region
by: Marcio Nahum Lobo, et al.
Published: (2022-12-01)

Effects of Pegylated Interferon Alpha and Ribavirin (pegIFN-α/RBV) Therapeutic Approach on Regulatory T Cells in HCV-Monoinfected and HCV/HIV-Coinfected Patients
by: Kamil Grubczak, et al.
Published: (2021-07-01)

Fast relapse and high drop out rate of 48 weeks daily interferon monotherapy in HIV-infected patients with chronic hepatitis C
by: Patruno Savino FA, et al.
Published: (2002-08-01)

Highlights from the 2012 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): from cART management to the search of an HIV cure
by: Lafeuillade Alain, et al.
Published: (2012-08-01)

Expanding epidemic of recently acquired HCV in HIV-coinfected patients over a period of 10 years
by: Christiana Graf, et al.
Published: (2023-07-01)

Outcome of direct-acting antiviral treatment in patients with hepatitis C virus/hepatitis B virus coinfection
by: El-Araby Mohamed Ibrahim Shalaby, et al.
Published: (2023-06-01)

IL28B gene polymorphisms in mono- and HIV-coinfected chronic hepatitis C patients
by: Bruna Cristina Bertol, et al.
Published: (2015-03-01)

Retention on antiretroviral therapy in person with HIV and viral hepatitis coinfection in Ethiopia: a retrospective cohort study
by: Eleni Seyoum, et al.
Published: (2022-04-01)

Comparison of Patients Monoinfected with Hepatitis C Virus and Coinfected with Hepatitis B/C in the Amazon Region of Brazil
by: Regiane M. A. Sampaio, et al.
Published: (2022-04-01)

Hepatitis B and C viral coinfections and their association with HIV viral load suppression among HIV-1 infected patients on ART at Mekelle hospital, northern Ethiopia
by: Gebrecherkos Teame, et al.
Published: (2022-12-01)

Evaluation of the therapeutic response of hepatitis C in coinfected patients (HIV/HCV): a study of cases from a hospital for chronic liver diseases in the Eastern Brazilian Amazon
by: Ivanete do Socorro Abraçado Amaral, et al.
Published: (2013-01-01)

Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection
by: Keeffe Emmet B, et al.
Published: (2005-09-01)

HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients
by: Óscar Brochado, et al.
Published: (2021-03-01)

Effect of Direct Antiviral Therapy Against HCV on CD4+ T Cell Count in Patients with HIV-HCV Coinfection
by: Pinchera B, et al.
Published: (2023-02-01)

Coinfection of HIV and hepatitis C increases complication rates after total joint arthroplasty
by: Fang Christopher, et al.
Published: (2020-01-01)

Impact of Lamivudine-Based Antiretroviral Treatment on Hepatitis B Viremia in HIV-Coinfected South Africans
by: Azwidowi Lukhwareni, et al.
Published: (2020-06-01)

Predictive plasma biomarkers of long-term increase in hepatic steatosis index after HCV eradication in HIV/HCV-coinfected patients
by: Rubén Martín-Escolano, et al.
Published: (2023-08-01)

CCR5+ T-Cells Homed to the Liver Exhibit Inflammatory and Profibrogenic Signatures in Chronic HIV/HCV-Coinfected Patients
by: Shikha Shrivastava, et al.
Published: (2021-10-01)

Regulatory T-lymphocyte subsets in patients with HIV-infection receiving highly active antiretroviral therapy
by: V. A. Chereshnev, et al.
Published: (2019-05-01)

IMMUNITY ACTIVATION IN HIV INFECTION
by: K. V. Shmagel, et al.
Published: (2017-10-01)

Increased Mortality in HIV Infected Individuals with Tuberculosis: A Retrospective Cohort Study, Addis Ababa, Ethiopia
by: Seyoum E, et al.
Published: (2022-03-01)

Barriers to treatment of hepatitis C in HIV/HCV coinfected adults in Brazil
by: Maria Cássia Mendes-Corrêa, et al.

Seroprevalence of hepatitis C virus among people living with HIV/AIDS in Latin America and the Caribbean: a systematic review
by: Fatima Mitiko Tengan, et al.
Published: (2016-11-01)

BACKGROUND OF THE SOCIAL ASPECTS OF COINFECTION BY TB / HIV IN FEDERAL DISTRICT
by: Alessandra Gelande de Sousa, et al.
Published: (2013-01-01)

High hepatitis C virus infection among female sex workers in Viet Nam: strong correlation with HIV and infection drug use
by: Linh-Vi N Le, et al.
Published: (2019-11-01)

Coinfection of tuberculosis/HIV at children and teenagers in Zaporizhzhia region
by: O. M. Raznatovskaya, et al.
Published: (2017-12-01)